… global RNA N6-methyladenosine (m 6 A) modification patterns in a mouse model of diabetic
cardiomyopathy (DCM). Patterns of m 6 A in DCM and normal hearts were analyzed via m 6 …

… NOTCH1 was reconstituted in ALKBH5- and YTHDF2-deficient cardiac fibroblasts and …
and diabetic cardiac fibrosis. Heart tissue samples from patients with diabetic cardiomyopathy …

… N6-methyladenosine (m 6 A) is the most abundant and … However, the exact roles of m 6
A in cardiovascular diseases (… m 6 A methylation in the progress of CVDs, such as cardiac …

… N 6 -methyladenosine (m 6 A) is the most prevalent modification in eukaryotic RNAs. This
reversible m 6 A RNA modification is dynamically regulated by writers, erasers, and readers, …

… N6-methyladenosine (m6A) is one of the most important epigenetic regulation of RNAs, …
However, the underlying regulatory mechanism of m6A in diabetic cardiomyopathy (DCM) is …

… N6-methyladenosine (m6A), 5-methylcytosine (m5C), N7-methylguanosine (m7G), N1-methyladenosine
(m1A), 2'-O-methylation (Nm), and 6,2'-… In the context of diabetic cardiac fibrosis, …

… dysfunction in patients with diabetes. However, the underlying mechanisms of cardiac
fibrosis … of cardiac fibrosis in diabetic cardiomyopathy (DCM) and its underlying mechanism. …

… The functional association between the regulation of m6A levels in blood and cardiac
dysfunction remains to be established, yet our data showing a positive correlation with cardiac …

N6-methyladenosine (m6A) modification is the most universal and abundant post-transcriptional
modification of eukaryotic RNA and occurs mainly at the consensus motif RR (m6A) CH (…

Dear Editor, RNA N6-methyladenines (m6A) not only play an essential role in normal biological
processes but also participate in the pathogenesis of diseases including type 2 diabetes …